FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891557077> ?p ?o ?g. }

• W2891557077 endingPage "2653" @default.
• W2891557077 startingPage "2643" @default.
• W2891557077 abstract "Abstract Enhanced permeability and retention (EPR) effect–based nanomedicine is a promising strategy for successful anticancer therapy. The EPR effect is based on tumor blood flow. Because advanced large tumors, as frequently seen in clinical settings, are heterogeneous, with regions of defective vasculature and blood flow, achieving the desired tumor drug delivery is difficult. Here, we utilized the EPR effect to increase drug delivery. To augment the EPR effect for improved therapeutic effects of nanomedicine, we exploited vascular mediators—the nitric oxide (NO) generators nitroglycerin (NG), hydroxyurea, and l-arginine. These compounds generate NO in tumors with relatively high selectivity. Using different nanosized drugs in our protocol significantly increased (1.5–2 times) delivery of nanomedicines to different solid tumor models, along with markedly improving (2–3-fold) the antitumor effects of these drugs. Also, in 7,12-dimethylbenz[a]anthracene–induced advanced end-stage breast cancer, often seen in clinical settings, 2 mg/kg polymer-conjugated pirarubicin (P-THP) with NG (0.2 mg/mouse) showed better effects than did 5 mg/kg P-THP, and 5 mg/kg P-THP used with NG resulted in cures or stable tumors (no tumor growth) for up to 120 days. Moreover, in a murine autochthonous azoxymethane/dextran sulfate sodium-induced colon cancer model, NO donors markedly improved the therapeutic effects of P-THP even after just one injection, results that were comparable with those achieved with three weekly P-THP treatments. These findings strongly suggest the potential usefulness of NO donors as EPR effect enhancers to improve the therapeutic efficacy of nanomedicines." @default.
• W2891557077 created "2018-09-27" @default.
• W2891557077 creator A5000236190 @default.
• W2891557077 creator A5009753049 @default.
• W2891557077 creator A5010475262 @default.
• W2891557077 creator A5040270800 @default.
• W2891557077 creator A5061590219 @default.
• W2891557077 creator A5066624795 @default.
• W2891557077 creator A5080816054 @default.
• W2891557077 date "2018-12-01" @default.
• W2891557077 modified "2023-10-11" @default.
• W2891557077 title "Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide–Generating Agents Improves the Therapeutic Effects of Nanomedicines" @default.
• W2891557077 cites W1021174652 @default.
• W2891557077 cites W1148781016 @default.
• W2891557077 cites W1644644121 @default.
• W2891557077 cites W1967945887 @default.
• W2891557077 cites W1969471545 @default.
• W2891557077 cites W1975429911 @default.
• W2891557077 cites W1976041621 @default.
• W2891557077 cites W1981993402 @default.
• W2891557077 cites W1985241728 @default.
• W2891557077 cites W1996275708 @default.
• W2891557077 cites W2013642104 @default.
• W2891557077 cites W2024253505 @default.
• W2891557077 cites W2025989684 @default.
• W2891557077 cites W2034769077 @default.
• W2891557077 cites W2036131736 @default.
• W2891557077 cites W2038882972 @default.
• W2891557077 cites W2044433401 @default.
• W2891557077 cites W2055483349 @default.
• W2891557077 cites W2059032684 @default.
• W2891557077 cites W2059504375 @default.
• W2891557077 cites W2066459637 @default.
• W2891557077 cites W2087414776 @default.
• W2891557077 cites W2087712848 @default.
• W2891557077 cites W2092527323 @default.
• W2891557077 cites W2095412415 @default.
• W2891557077 cites W2100886293 @default.
• W2891557077 cites W2106629884 @default.
• W2891557077 cites W2127640925 @default.
• W2891557077 cites W2139438973 @default.
• W2891557077 cites W2150575159 @default.
• W2891557077 cites W2156969927 @default.
• W2891557077 cites W2161946327 @default.
• W2891557077 cites W2168143310 @default.
• W2891557077 cites W2170315635 @default.
• W2891557077 cites W2170397758 @default.
• W2891557077 cites W2171351423 @default.
• W2891557077 cites W2331177167 @default.
• W2891557077 cites W2333562831 @default.
• W2891557077 cites W2614391499 @default.
• W2891557077 cites W2761903020 @default.
• W2891557077 cites W2799710201 @default.
• W2891557077 cites W2806123710 @default.
• W2891557077 doi "https://doi.org/10.1158/1535-7163.mct-18-0696" @default.
• W2891557077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30232144" @default.
• W2891557077 hasPublicationYear "2018" @default.
• W2891557077 type Work @default.
• W2891557077 sameAs 2891557077 @default.
• W2891557077 citedByCount "81" @default.
• W2891557077 countsByYear W28915570772019 @default.
• W2891557077 countsByYear W28915570772020 @default.
• W2891557077 countsByYear W28915570772021 @default.
• W2891557077 countsByYear W28915570772022 @default.
• W2891557077 countsByYear W28915570772023 @default.
• W2891557077 crossrefType "journal-article" @default.
• W2891557077 hasAuthorship W2891557077A5000236190 @default.
• W2891557077 hasAuthorship W2891557077A5009753049 @default.
• W2891557077 hasAuthorship W2891557077A5010475262 @default.
• W2891557077 hasAuthorship W2891557077A5040270800 @default.
• W2891557077 hasAuthorship W2891557077A5061590219 @default.
• W2891557077 hasAuthorship W2891557077A5066624795 @default.
• W2891557077 hasAuthorship W2891557077A5080816054 @default.
• W2891557077 hasBestOaLocation W28915570771 @default.
• W2891557077 hasConcept C102652120 @default.
• W2891557077 hasConcept C126322002 @default.
• W2891557077 hasConcept C15083742 @default.
• W2891557077 hasConcept C155672457 @default.
• W2891557077 hasConcept C171250308 @default.
• W2891557077 hasConcept C178790620 @default.
• W2891557077 hasConcept C185592680 @default.
• W2891557077 hasConcept C192562407 @default.
• W2891557077 hasConcept C2776085618 @default.
• W2891557077 hasConcept C2776694085 @default.
• W2891557077 hasConcept C2779820397 @default.
• W2891557077 hasConcept C2780035454 @default.
• W2891557077 hasConcept C502942594 @default.
• W2891557077 hasConcept C519581460 @default.
• W2891557077 hasConcept C71924100 @default.
• W2891557077 hasConcept C98274493 @default.
• W2891557077 hasConceptScore W2891557077C102652120 @default.
• W2891557077 hasConceptScore W2891557077C126322002 @default.
• W2891557077 hasConceptScore W2891557077C15083742 @default.
• W2891557077 hasConceptScore W2891557077C155672457 @default.
• W2891557077 hasConceptScore W2891557077C171250308 @default.
• W2891557077 hasConceptScore W2891557077C178790620 @default.
• W2891557077 hasConceptScore W2891557077C185592680 @default.
• W2891557077 hasConceptScore W2891557077C192562407 @default.

• next